US Stocks
VRPX
Virpax Pharmaceuticals, Inc. Common Stock
$0.0011
+0.0000 (+0.00%)
Volume:
0 ($0.00)
Market Capitalization:
-
Virpax Pharmaceuticals Price Chart
*There is no price data available for this ticker
Virpax Pharmaceuticals Volume Chart
*There is no volume data available for this ticker
Virpax Pharmaceuticals Market Segments
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
+0.0001(+10.00%)
| Open | $0.0010 |
|---|---|
| Close | $0.0011 |
| Low | $0.0010 |
| Low Change | 0.0000 (0.00%) |
| High | $0.0011 |
| High Change | +0.0001 (+10.00%) |
| Range | $0.0001 |
| Volume | 9.969K |
| Dollar Volume | $10.97 |
Premarket Yesterday
*No Trades in Segment
Virpax Pharmaceuticals Moving Averages
| 5 Day Moving Average (SMA5) | $0.0026 |
|---|---|
| 10 Day Moving Average (SMA10) | $0.0047 |
| 20 Day Moving Average (SMA20) | $0.0078 |
| 50 Day Moving Average (SMA50) | $0.0155 |
| 100 Day Moving Average (SMA100) | $0.0160 |
| 200 Day Moving Average (SMA200) | $0.4766 |
Virpax Pharmaceuticals Statistics
| Average Volume (30 Days) | 1.13K |
|---|---|
| P/E Ratio (Current) | .00 |
| EPS (Current) | -$9.71 |
| Dividend Yield | — |
| Free Cash Flow | — |
| Cash Ratio | 0.61 |
| Current Ratio | 0.63 |
| Quick Ratio | 0.63 |
| Debt to Equity | 0.00 |
| Enterprise Value | -$1.51M |
| EV to EBITDA | 0.13 |
| EV to Sales | — |
| Price to Book | 0.00 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -7.76% |
| Return on Equity | 13.21% |
Virpax Pharmaceuticals Stock Splits
There have been 2 stock splits for Virpax Pharmaceuticals (VRPX). The last reverse stock split occured on March 21, 2025 and reduced the outstanding shares at a ratio of 25:1.
| Date | Type | Ratio |
|---|---|---|
| Mar 21, 2025 | Reverse | 25:1 |
| Mar 1, 2024 | Reverse | 10:1 |
Virpax Pharmaceuticals Dividends
There have been no dividends for Virpax Pharmaceuticals (VRPX).